Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 1/2013

01-02-2013 | Case Report

Hepatectomy in a hepatocellular carcinoma case with Dubin–Johnson syndrome and indocyanine green excretory defect

Authors: Hideki Aoki, Toshiaki Morihiro, Takashi Arata, Nobuhiko Kanaya, Shou Takeda, Takayuki Ninomiya, Masayuki Seita, Kou Katsuda, Kohji Tanakaya, Hitoshi Takeuchi

Published in: Clinical Journal of Gastroenterology | Issue 1/2013

Login to get access

Abstract

A 77-year-old male patient with history of jaundice was referred to our hospital for treatment of hepatocellular carcinoma (HCC). He was found to have Dubin–Johnson syndrome (DJS), a clinical feature of constitutional jaundice with conjugated hyperbilirubinemia, and indocyanine green (ICG) excretory defect, both of which are rare conditions. Total bilirubin was 5.1 mg/dl and ICG retention at 15 min (ICGR15) (77.1 %). Converted ICGR15 from GSA scintigraphy was 15.9 %. Resection of the medial segment and ventral region of the anterior segment of the liver as well as cholecystectomy were performed. The background of the liver tissue was blackish yellow and consistent with DJS and chronic hepatitis. Although total bilirubin level increased to 8.2 mg/dl on the 2nd postoperative day, the patient ultimately recovered and he was discharged on the 14th day. His 1- and 2-year medical checkups indicated recurrence of HCC. He underwent transarterial chemoembolization and is presently doing well 39 months after surgery. We report here on evaluation and treatment of patients with such disorders.
Literature
1.
go back to reference Kawamura H, Kamiyama T, Nakagawa T, Nakanishi K, Yokoo H, Tahara M, et al. Preoperative evaluation of hepatic functional reserve by converted ICGR15 calculated from 99mTc-GSA scintigraphy. J Gastroenterol Hepatol. 2008;23:1235–41.PubMedCrossRef Kawamura H, Kamiyama T, Nakagawa T, Nakanishi K, Yokoo H, Tahara M, et al. Preoperative evaluation of hepatic functional reserve by converted ICGR15 calculated from 99mTc-GSA scintigraphy. J Gastroenterol Hepatol. 2008;23:1235–41.PubMedCrossRef
2.
go back to reference Yamanaka N, Okamoto E, Oriyama T, Fujimoto J, Furukawa K, Kawamura E, et al. A prediction scoring system to select the surgical treatment of liver cancer. Further refinement based on 10 years of use. Ann Surg. 1994;219:342–6.PubMedCrossRef Yamanaka N, Okamoto E, Oriyama T, Fujimoto J, Furukawa K, Kawamura E, et al. A prediction scoring system to select the surgical treatment of liver cancer. Further refinement based on 10 years of use. Ann Surg. 1994;219:342–6.PubMedCrossRef
3.
go back to reference Rastogi A, Krishnani N, Pandey R. Dubin–Johnson syndrome—a clinicopathologic study of twenty cases. Indian J Pathol Microbiol. 2006;49:500–4.PubMed Rastogi A, Krishnani N, Pandey R. Dubin–Johnson syndrome—a clinicopathologic study of twenty cases. Indian J Pathol Microbiol. 2006;49:500–4.PubMed
4.
go back to reference Osawa G, Shiozawa S, Tsuchiya A, Kim DH, Naritaka Y, Ogawa K. A case of hepatocellular carcinoma accompanied with Dubin–Johnson syndrome (in Japanese with English abstract). Nihon Rinsho Geka Gakkai Zasshi (J Jpn Surg Assoc). 2007;68:2061–6.CrossRef Osawa G, Shiozawa S, Tsuchiya A, Kim DH, Naritaka Y, Ogawa K. A case of hepatocellular carcinoma accompanied with Dubin–Johnson syndrome (in Japanese with English abstract). Nihon Rinsho Geka Gakkai Zasshi (J Jpn Surg Assoc). 2007;68:2061–6.CrossRef
5.
go back to reference Mullen JT, Ribero D, Reddy SK, Donadon M, Zorzi D, Gautam S, et al. Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg. 2007;204:854–62.PubMedCrossRef Mullen JT, Ribero D, Reddy SK, Donadon M, Zorzi D, Gautam S, et al. Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg. 2007;204:854–62.PubMedCrossRef
6.
go back to reference Kadono J, Kumemura H, Nishida S, Nakamura N, Gejima K, Nakajo M, et al. 99mTc-DTPA-Galactosyl-human-serum-albumin liver scintigraphy for evaluating hepatic functional reserve before hepatectomy in a patient with indocyanine green excretory defect: report of a case. Surg Today. 2006;36:481–4.PubMedCrossRef Kadono J, Kumemura H, Nishida S, Nakamura N, Gejima K, Nakajo M, et al. 99mTc-DTPA-Galactosyl-human-serum-albumin liver scintigraphy for evaluating hepatic functional reserve before hepatectomy in a patient with indocyanine green excretory defect: report of a case. Surg Today. 2006;36:481–4.PubMedCrossRef
7.
go back to reference Nambu M, Namihisa T. Hepatic transport of serum bilirubin, bromsulfophthalein, and indocyanine green in patients with congenital non-hemolytic hyperbilirubinemia and patients with constitutional indocyanine green excretory defect. J Gastroenterol. 1996;31:228–36.PubMedCrossRef Nambu M, Namihisa T. Hepatic transport of serum bilirubin, bromsulfophthalein, and indocyanine green in patients with congenital non-hemolytic hyperbilirubinemia and patients with constitutional indocyanine green excretory defect. J Gastroenterol. 1996;31:228–36.PubMedCrossRef
8.
go back to reference Makuuchi M, Kosuge T, Takayama T, Yamazaki S, Kakazu T, Miyagawa S, et al. Surgery for small liver cancers. Semin Surg Oncol. 1993;9:298–304.PubMedCrossRef Makuuchi M, Kosuge T, Takayama T, Yamazaki S, Kakazu T, Miyagawa S, et al. Surgery for small liver cancers. Semin Surg Oncol. 1993;9:298–304.PubMedCrossRef
9.
go back to reference Yokoyama Y, Nishio H, Ebata T, Igami T, Sugawara G, Nagino M. Value of indocyanine green clearance of the future liver remnant in predicting outcome after resection for biliary cancer. Br J Surg. 2010;97:1260–8.PubMedCrossRef Yokoyama Y, Nishio H, Ebata T, Igami T, Sugawara G, Nagino M. Value of indocyanine green clearance of the future liver remnant in predicting outcome after resection for biliary cancer. Br J Surg. 2010;97:1260–8.PubMedCrossRef
10.
go back to reference Oussoultzoglou E, Jaeck D, Addeo P, Fuchshuber P, Marzano E, Rosso E, et al. Prediction of mortality rate after major hepatectomy in patients without cirrhosis. Arch Surg. 2010;145:1075–81.PubMedCrossRef Oussoultzoglou E, Jaeck D, Addeo P, Fuchshuber P, Marzano E, Rosso E, et al. Prediction of mortality rate after major hepatectomy in patients without cirrhosis. Arch Surg. 2010;145:1075–81.PubMedCrossRef
11.
12.
go back to reference Lee WC, Chen M-F. Assessment of hepatic reserve for indication of hepatic resection: how I do it. J Hepatobiliary Pancreat Surg. 2005;12:23–36.PubMedCrossRef Lee WC, Chen M-F. Assessment of hepatic reserve for indication of hepatic resection: how I do it. J Hepatobiliary Pancreat Surg. 2005;12:23–36.PubMedCrossRef
13.
go back to reference Radaelli CA, Dufour JF, Wagner M, Schilling M, Husler J, Krahenbuhl L, et al. Preoperative galactose elimination capacity predicts complication and survival after hepatic resection. Ann Surg. 2002;235:77–85.CrossRef Radaelli CA, Dufour JF, Wagner M, Schilling M, Husler J, Krahenbuhl L, et al. Preoperative galactose elimination capacity predicts complication and survival after hepatic resection. Ann Surg. 2002;235:77–85.CrossRef
Metadata
Title
Hepatectomy in a hepatocellular carcinoma case with Dubin–Johnson syndrome and indocyanine green excretory defect
Authors
Hideki Aoki
Toshiaki Morihiro
Takashi Arata
Nobuhiko Kanaya
Shou Takeda
Takayuki Ninomiya
Masayuki Seita
Kou Katsuda
Kohji Tanakaya
Hitoshi Takeuchi
Publication date
01-02-2013
Publisher
Springer Japan
Published in
Clinical Journal of Gastroenterology / Issue 1/2013
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-012-0347-9

Other articles of this Issue 1/2013

Clinical Journal of Gastroenterology 1/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.